No Data
Beijing Centergate Technologies (000931.SZ): Subsidiary company Duoduo Pharmaceutical received the "Acceptance Notice" for Nifurtimox tablets from the National Medical Products Administration.
November 12th, Beijing Centergate Technologies (000931.SZ) announced that its subsidiary, Duoduo Pharmaceutical, recently received the "Acceptance Letter" issued by the National Medical Products Administration, accepting the registration application for Febuxostat tablets (specifications: 20mg, 40mg). Duoduo Pharmaceutical's Febuxostat tablets (specifications: 20mg, 40mg) were launched for research in 2022, and the indication for this application is for the long-term treatment of hyperuricemia in gout patients, not recommended for hyperuricemia without clinical symptoms.
Zhongguancun: Report for the third quarter of 2024
Beijing Centergate Technologies (000931.SZ) released its performance for the first three quarters, with net income of 51.629 million yuan, a year-on-year increase of 24.78%.
Beijing Centergate Technologies (000931.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue of 1...
beijing centergate technologies (000931.SZ) net income for the first three quarters was 51.629 million yuan, a year-on-year increase of 24.78%.
Gelonghui on October 30th, Beijing Centergate Technologies (000931.SZ) released the third quarter report, the company achieved revenue of 1.93 billion yuan in the first three quarters, a year-on-year increase of 14.96%; net income was 51.629 million yuan, a year-on-year increase of 24.78%. In the third quarter alone, revenue reached 0.656 billion yuan, an increase of 22.41% year-on-year; net income was 15.2391 million yuan.
Beijing centergate technologies (000931.SZ): Subsidiary company Beijing Huasu has obtained an invention patent certificate.
On September 27, Gelonghui announced that its subsidiary Beijing Huasu Pharmaceutical Co., Ltd., under Beijing Centergate Technologies (000931.SZ), recently obtained a patent for invention issued by the National Intellectual Property Administration, with the invention named as a bisoprolol formulation and its preparation method.
Beijing Centergate Technologies (000931.SZ), a subsidiary of the company, plans to acquire 51% equity of Guomei Internet Hospital for 0 yuan to expand its retirement medical business.
beijing centergate technologies (000931.SZ) announcement, the company's wholly-owned subsidiary beijing huasutang csi old-age industry investment co., ltd. (abbreviated...
No Data
No Data